ESC 365 - Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

ESC Professional Premium Access

Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes

Session: Insights into arrhythmia mechanisms

Topic: Cellular Mechanisms of Arrhythmias

Speaker: Miss A. Paasche (Heidelberg, DE)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Miss Amelie Paasche

Heidelberg (Germany)

0 follower

2 more presentations in this session

State-of-the-art lecture in arrhythmia mechanisms.

Speaker: Professor U. Schotten (Maastricht, NL)

Dapagliflozin but not empagliflozin prevents atrial fibrillation in an experimental whole-heart model

Speaker: Professor G. Frommeyer (Munster, DE)

Access the full session

Insights into arrhythmia mechanisms

Speakers: Miss A. Paasche, Professor U. Schotten, Professor G. Frommeyer

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by